These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8653799)

  • 21. Relation between renal and hepatic excretion of drugs: XV. Organ distribution and transport of the new antiarrhythmic drug Bonnecor in kidney and liver of rats.
    Fleck C; Bräunlich H
    Exp Pathol; 1991; 42(3):137-44. PubMed ID: 1915757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis.
    Fukuda M; Yamanaka T; Mizuno M; Motokawa M; Shirasawa Y; Miyagi S; Nishio T; Yoshida A; Kimura G
    J Hypertens; 2008 Mar; 26(3):583-8. PubMed ID: 18300871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronopharmacology of high-dose busulfan in children.
    Vassal G; Challine D; Koscielny S; Hartmann O; Deroussent A; Boland I; Valteau-Couanet D; Lemerle J; Lévi F; Gouyette A
    Cancer Res; 1993 Apr; 53(7):1534-7. PubMed ID: 8453619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The anti-arrhythmia properties of bonnecor metabolites].
    Grigor'eva EK; Poppe H; Tolmacheva EA; Krasnykh LM
    Farmakol Toksikol; 1990; 53(3):48-50. PubMed ID: 2387382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of morning or evening administration on absorption of theophylline.
    Su YM; Cheng TP; Yeh TW; Wen CY; Wang DI
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):113-8. PubMed ID: 10677921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the binding characteristics of class I antiarrhythmic agents for human muscarinic m1-m3 receptors.
    Yamamoto N; Ozaki T; Keida Y; Ohtsuka M; Goto T
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):53-9. PubMed ID: 10413067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal variation in the pharmacokinetics of nizatidine in healthy volunteers and in patients with peptic ulcer disease.
    Jamali F; Thomson AB; Kirdeikis P; Tavernini M; Zuk L; Marriage B; Simpson I; Mahachai V
    J Clin Pharmacol; 1995 Nov; 35(11):1071-5. PubMed ID: 8626880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolism of flecainide.
    Conard GJ; Ober RE
    Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seadragon VI: a 7-day dry saturation dive at 31 ATA. IV. Circadian analysis of body temperature and renal functions.
    Konda N; Shiraki K; Takeuchi H; Nakayama H; Hong SK
    Undersea Biomed Res; 1987 Sep; 14(5):413-23. PubMed ID: 3672652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The relationship between the physicochemical and pharmacokinetic parameters and the anti-arrhythmia activity of bonnecor and its metabolites].
    Rodionov AP; Zolotov NN; Lyskovtsev VV; Zalilov KIu; Poppe H
    Farmakol Toksikol; 1990; 53(3):50-1. PubMed ID: 2387383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension.
    Fujii T; Uzu T; Nishimura M; Takeji M; Kuroda S; Nakamura S; Inenaga T; Kimura G
    Am J Kidney Dis; 1999 Jan; 33(1):29-35. PubMed ID: 9915264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A; Vande Walle C; Van Sintjan P; Donckerwolcke R; Raes A; Dehoorne J; Van Laecke E; Hoebeke P; Vande Walle J
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood pressure rhythm and endocrine functions in normotensive women on oral contraceptives.
    Heintz B; Schmauder C; Witte K; Breuer I; Baltzer K; Sieberth HG; Lemmer B
    J Hypertens; 1996 Mar; 14(3):333-9. PubMed ID: 8723987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal circadian rhythm of diuresis or nocturnal polyuria in a subgroup of children with enuresis and hypercalciuria is related to increased sodium retention during daytime.
    Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Donckerwolcke R; Vande Walle J
    J Urol; 2006 Sep; 176(3):1147-51. PubMed ID: 16890713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pharmacokinetics and metabolism of bonnecor in rats].
    Klemm V; Morgenroth U; Starke F; Zeriatke W; Ioram U
    Farmakol Toksikol; 1990; 53(3):43-4. PubMed ID: 2387379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.